SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

Sciensus Pharma Services Limitedの戦略的SWOTインサイト

Sciensus Pharma Services Limited - Strategic SWOT Insights

Sciensus Pharma Services Limitedの戦略的SWOTインサイト：機会、課題、リスクの360度レビュー、企業とESG戦略、競合情報と経営KPI、最新動向
Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends
出版社Quaintel Research
出版年月2025年6月
ページ数70
価格タイプシングルユーザライセンス
価格150
種別英文調査報告書

Report Overview

Report Summary

Sciensus Pharma Services Limited – Strategic SWOT Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of Sciensus Pharma Services Limited ‘s business operations. It provides a detailed analysis of the company’s strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about Sciensus Pharma Services Limited including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses Sciensus Pharma Services Limited’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Sciensus Pharma Services Limited’s overall strategic standing and supports informed decision-making and strategic planning.

Finally, the report includes recent news and deal activities undertaken by Sciensus Pharma Services Limited enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

Sciensus Pharma Services Limited, formerly known as Healthcare at Home, is a leading pharmaceutical supplier and home healthcare provider based in Burton on Trent, UK. Established in 1992 by founder and former chairman Charles Walsh, the company has grown to employ around 1,700 people and serve over 230,000 patients annually across the UK.The company’s core services include pharmaceutical supply and distribution, home healthcare services, and specialty pharmacy services.

Sciensus supplies a wide range of pharmaceuticals to patients, healthcare providers, and pharmaceutical companies, working with every NHS trust in the UK to ensure patients have access to the medications they need. The company also specializes in providing in-home care for patients with long-term conditions, rare diseases, and cancer, with a team of healthcare professionals delivering treatments and therapies directly to patients’ homes, improving access and convenience.

Additionally, Sciensus offers bespoke services to connect pharmaceutical companies, insurers, and healthcare professionals with patients who require rare, orphan, or hard-to-access medications, including global distribution and patient support programs.However, in 2023, Sciensus faced regulatory issues, including a partial suspension of its license by the MHRA following an incident involving unlicensed chemotherapy treatments. The company was also given a warning by the Parliamentary and Health Service Ombudsman regarding its complaints handling process. Despite these challenges, Sciensus remains a significant player in the UK’s healthcare landscape, providing essential services to thousands of patients.

Sciensus Pharma Services Limited in the News:-

– 13-May-2025 – Sciensus achieves 95% patient satisfaction and record NPS
– 23-Apr-2025 – Sciensus achieves ISO 14001 accreditation
– 23-Apr-2025 – Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities
– 02-Apr-2025 – Sciensus Easter 2025 bank holiday opening hours
– 28-Feb-2025 – Sciensus’ new depot allows for increased capacity and improved environmental and social impact

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Sciensus Pharma Services Limited’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Sciensus Pharma Services Limited’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the Sciensus Pharma Services Limited’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Sciensus Pharma Services Limited’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Sciensus Pharma Services Limited’s internal and external factors through SWOT analysis and Corporate Strategy.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Sciensus Pharma Services Limited:

• Sciensus Pharma Services Limited PESTLE Analysis
• Sciensus Pharma Services Limited Value Chain Analysis
• Sciensus Pharma Services Limited Porter’s Five Forces Analysis
• Sciensus Pharma Services Limited VRIO Analysis
• Sciensus Pharma Services Limited BCG Analysis
• Sciensus Pharma Services Limited Segmentation, Targeting and Positioning (STP) Analysis
• Sciensus Pharma Services Limited Ansoff Matrix Analysis

Table of Contents

Table of Contents
Table of Contents 2
Tables 5
Charts 6
Sciensus Pharma Services Limited – Key Company Facts 7
Sciensus Pharma Services Limited – Company Description 8
Sciensus Pharma Services Limited – Top Executives 9
Sciensus Pharma Services Limited – Head Office & Locations 10
Head Office – Country 10
Sciensus Pharma Services Limited – Products and Services 11
Services 11
Sciensus Pharma Services Limited – Corporate Strategy 13
Sciensus Pharma Services Limited – Business Description 16
Homecare Services 16
Clinical Services 17
Supply Chain Solutions 17
Consulting and Support Services 18
Sciensus Pharma Services Limited – ESG Spotlight 19
Environment 19
Social 19
Corporate Governance 20
Sciensus Pharma Services Limited – SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 27
Threats 29
Competing Players 30
Snapshot of Competing Players 31
Health Catalyst Inc. 31
Key Company Facts 31
Company Description 31
Key Financials 32
Share Price Trend – Jan-2024 to Jun-2025 (Average Share Closing Price) 32
Key Financial Ratio Analysis 37
NextGen Healthcare Inc. 38
Key Company Facts 38
Company Description 38
Veeva Systems Inc 39
Key Company Facts 39
Company Description 39
Key Financials 40
Share Price Trend – May-2024 to Jun-2025 (Average Share Closing Price) 40
Key Financial Ratio Analysis 45
athenahealth Inc 46
Key Company Facts 46
Company Description 46
Phreesia Inc 47
Key Company Facts 47
Company Description 47
Key Financials 48
Share Price Trend – Jan-2024 to Jun-2025 (Average Share Closing Price) 48
Key Financial Ratio Analysis 53
Sciensus Pharma Services Limited – In the News 54
13-May-2025- Sciensus achieves 95% patient satisfaction and record NPS 54
23-Apr-2025- Sciensus achieves ISO 14001 accreditation 55
23-Apr-2025- Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities 57
02-Apr-2025- Sciensus Easter 2025 bank holiday opening hours 58
28-Feb-2025- Sciensus’ new depot allows for increased capacity and improved environmental and social impact 59
20-Jun-2024- Personalised Vaccines and Cancer Treatment 60
10-May-2024- Sciensus hosts a panel at the World Orphan Drug Congress 2024 61
08-May-2024- Sciensus partners with Observia to improve medication adherence through behavioural insights 63
29-Feb-2024- Sciensus partners with ITN and Genetic Alliance UK for Rare Disease Day 65
28-Feb-2024- Sciensus to integrate pathology test results into iQemo 66
Appendix 67
Definitions 67
SWOT Analysis 67
PESTLE Analysis 67
Value Chain Analysis 67
ESG Spotlight 67
Research Methodology 68
Disclaimer 69
Contact Us 69

Tables
Table 1: Sciensus Pharma Services Limited – Company Facts
Table 2: Sciensus Pharma Services Limited – Digital Presence
Table 3: Sciensus Pharma Services Limited – Top Executives
Table 4: Sciensus Pharma Services Limited – Services
Table 5: Sciensus Pharma Services Limited -Competing Players
Table 6: Competing Players – Health Catalyst Inc. – Key Company Facts
Table 7: Health Catalyst Inc. – Share Price Trend – Jan-2024 to Jun-2025
Table 8: Competing Players – Health Catalyst Inc. – Profit and Loss Statement
Table 9: Health Catalyst Inc. – Balance Sheet 2021-2024
Table 10: Health Catalyst Inc. – Cash Flow Statement 2021-2024
Table 11: Health Catalyst Inc. – Ratio Analysis – 2020-2023
Table 12: Competing Players – NextGen Healthcare Inc. – Key Company Facts
Table 13: Competing Players – Veeva Systems Inc – Key Company Facts
Table 14: Veeva Systems Inc – Share Price Trend – May-2024 to Jun-2025
Table 15: Competing Players – Veeva Systems Inc – Profit and Loss Statement
Table 16: Veeva Systems Inc – Balance Sheet 2021-2024
Table 17: Veeva Systems Inc – Cash Flow Statement 2021-2024
Table 18: Veeva Systems Inc – Ratio Analysis – 2021-2024
Table 19: Competing Players – athenahealth Inc – Key Company Facts
Table 20: Competing Players – Phreesia Inc – Key Company Facts
Table 21: Phreesia Inc – Share Price Trend – Jan-2024 to Jun-2025
Table 22: Competing Players – Phreesia Inc – Profit and Loss Statement
Table 23: Phreesia Inc – Balance Sheet 2021-2024
Table 24: Phreesia Inc – Cash Flow Statement 2021-2024
Table 25: Phreesia Inc – Ratio Analysis – 2021-2024

Charts
Figure 1: Sciensus Pharma Services Limited – SWOT Analysis22
Figure 2: Health Catalyst Inc. – Average Share Price Trend -Jan-2024 to Jun-202533
Figure 3: Health Catalyst Inc. – Profit and Loss Statement – 2021-202434
Figure 4: Health Catalyst Inc. – Balance Sheet – 2021-202435
Figure 5: Health Catalyst Inc. – Cash Flow Statement 2021-202436
Figure 6: Veeva Systems Inc – Average Share Price Trend -May-2024 to Jun-202541
Figure 7: Veeva Systems Inc – Profit and Loss Statement – 2021-202442
Figure 8: Veeva Systems Inc – Balance Sheet – 2021-202443
Figure 9: Veeva Systems Inc – Cash Flow Statement 2021-202444
Figure 10: Phreesia Inc – Average Share Price Trend -Jan-2024 to Jun-202549
Figure 11: Phreesia Inc – Profit and Loss Statement – 2021-202450
Figure 12: Phreesia Inc – Balance Sheet – 2021-202451
Figure 13: Phreesia Inc – Cash Flow Statement 2021-202452

医療・医薬の最新記事8件